版本:
中国

BRIEF-Interpace Diagnostics reports agreement to restructure debt

March 23 Interpace Diagnostics Group Inc :

* Interpace Diagnostics Group announces agreements to successfully restructure debt and terminate royalty and milestone obligations

* Interpace Diagnostics Group - will issue to Redpath 5-year warrants to acquire an aggregate of 100,000 shares of its common stock at $4.69 per share

* Interpace Diagnostics Group - Redpath agreed to terminate all future royalty and milestone obligations as a result of company's acquisition of Redpath

* Interpace Diagnostics - outstanding secured debt to Redpath of $9.34 million is being acquired for approximately $8.9 million by an institutional investor Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐